SHANA TESKE: Open Payments
NPI 1811521883 · BOURBONNAIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,456 in 178 payments from 20 companies in 2025. Trend: 2023 $1,230 · 2024 $3,052 · 2025 $3,456
Food & beverage: $3,421Education: $35
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 53 | $765 |
| ABBVIE INC. | 37 | $587 |
| GENZYME CORPORATION | 11 | $329 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $286 |
| Aimmune Therapeutics, Inc. | 7 | $247 |
| Celltrion USA Inc. | 11 | $240 |
| Ardelyx, Inc. | 8 | $181 |
| Gilead Sciences, Inc. | 6 | $124 |
| VIVUS LLC | 6 | $111 |
| QOL Medical, LLC | 5 | $97 |
Products named: TREMFYA, DUPIXENT, VEGZELMA, LINZESS, IBSRELA, ZENPEP, RINVOQ, SKYRIZI.
Industry payments across IL — which companies pay providers there.
